Zuowen He

1095# Jiefang Avenue
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids.

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids.

Journal: Journal of molecular and cellular cardiology

Published: June 02, 2023

The roles of eicosanoids in myocardial diseases.

The roles of eicosanoids in myocardial diseases.

Journal: Advances in pharmacology (San Diego, Calif.)

Published: May 26, 2023

Vasospastic angina: Past, present, and future.

Vasospastic angina: Past, present, and future.

Journal: Pharmacology & therapeutics

Published: May 15, 2023

Olfactory receptor 2 activation in macrophages: novel mediator of atherosclerosis progression.

Olfactory receptor 2 activation in macrophages: novel mediator of atherosclerosis progression.

Journal: Signal transduction and targeted therapy

Published: June 19, 2022

Epoxyeicosatrienoic acid: A potential therapeutic target of heart failure with preserved ejection fraction.

Epoxyeicosatrienoic acid: A potential therapeutic target of heart failure with preserved ejection fraction.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 19, 2022

CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory Mediators.

CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory Mediators.

Journal: Molecules (Basel, Switzerland)

Published: May 14, 2022

Chlorpromazine Efficiently Treats the Crisis of Pheochromocytoma: Four Case Reports and Literature Review.

Chlorpromazine Efficiently Treats the Crisis of Pheochromocytoma: Four Case Reports and Literature Review.

Journal: Frontiers in cardiovascular medicine

Published: August 21, 2021

Single-case metanalysis of fat embolism syndrome.

Single-case metanalysis of fat embolism syndrome.

Journal: International journal of cardiology

Published: August 01, 2021

Adenosine 2A Receptor Activation Contributes to Ang II-Induced Aortic Remodeling by Promoting Macrophage Retention.

Adenosine 2A Receptor Activation Contributes to Ang II-Induced Aortic Remodeling by Promoting Macrophage Retention.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: December 03, 2019

Trimetazidine Inhibits Renal Tubular Epithelial Cells to Mesenchymal Transition in Diabetic Rats via Upregulation of Sirt1.

Trimetazidine Inhibits Renal Tubular Epithelial Cells to Mesenchymal Transition in Diabetic Rats via Upregulation of Sirt1.

Journal: Frontiers in pharmacology

Published: October 17, 2019

CYP2J2 metabolites, epoxyeicosatrienoic acids, attenuate Ang II-induced cardiac fibrotic response by targeting Gα12/13.

CYP2J2 metabolites, epoxyeicosatrienoic acids, attenuate Ang II-induced cardiac fibrotic response by targeting Gα12/13.

Journal: Journal of lipid research

Published: December 13, 2016

Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II.

Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II.

Journal: Cardiovascular research

Published: January 26, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026